Lingfeng Yang

1.9k total citations
53 papers, 1.1k citations indexed

About

Lingfeng Yang is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Lingfeng Yang has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Oncology. Recurrent topics in Lingfeng Yang's work include Diabetes Treatment and Management (8 papers), Prostate Cancer Treatment and Research (8 papers) and Diabetes Management and Research (7 papers). Lingfeng Yang is often cited by papers focused on Diabetes Treatment and Management (8 papers), Prostate Cancer Treatment and Research (8 papers) and Diabetes Management and Research (7 papers). Lingfeng Yang collaborates with scholars based in United States, United Kingdom and China. Lingfeng Yang's co-authors include Lynn E. Eberly, Baanie Sawhney, Jerome D. Cohen, Ronald J. Prineas, Swapnil Rajpathak, Kristy Iglay, Tracey Weiss, Robert Boggs, Richard D. Carr and Sameer R. Ghate and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Lingfeng Yang

52 papers receiving 1.1k citations

Peers

Lingfeng Yang
Jiali Liu China
Raktim K. Ghosh United States
Timothy J. Vittorio United States
Nitika Gupta United States
Deborah Panebianco United States
John F. Setaro United States
Jiali Liu China
Lingfeng Yang
Citations per year, relative to Lingfeng Yang Lingfeng Yang (= 1×) peers Jiali Liu

Countries citing papers authored by Lingfeng Yang

Since Specialization
Citations

This map shows the geographic impact of Lingfeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng Yang more than expected).

Fields of papers citing papers by Lingfeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng Yang. The network helps show where Lingfeng Yang may publish in the future.

Co-authorship network of co-authors of Lingfeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfeng Yang. A scholar is included among the top collaborators of Lingfeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfeng Yang. Lingfeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Weihao, Huiping Zhu, Tian Wang, et al.. (2025). Temperature effect on the oxygen control efficiency of LSCF-type oxygen pump for LBE. Progress in Nuclear Energy. 186. 105804–105804.
2.
Yin, Jianbin, Jia-Luo Huang, Liangliang Liu, et al.. (2024). Macrophage-derived ectosomal miR-350-3p promotes osteoarthritis progression through downregulating chondrocyte H3K36 methyltransferase NSD1. Cell Death Discovery. 10(1). 223–223. 10 indexed citations
3.
Zhu, Huiping, Lingfeng Yang, Xiaobo Li, et al.. (2023). Performance of potentiometric oxygen sensors with LSCF electrode in lead–bismuth eutectic loop. Annals of Nuclear Energy. 190. 109909–109909. 4 indexed citations
4.
Zhu, Huiping, Xiaobo Li, Yifeng Wang, et al.. (2023). Experimental studies on active oxygen control performance of solid PbO mass exchanger in liquid lead–bismuth eutectic loop. Annals of Nuclear Energy. 192. 109977–109977. 5 indexed citations
5.
Yang, Xi‐Ding, Ronghua Zhu, Jing Zhang, et al.. (2023). First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain. Expert Opinion on Investigational Drugs. 32(6). 553–562. 3 indexed citations
6.
Shore, Neal D., Raluca Ionescu‐Ittu, François Laliberté, et al.. (2021). Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study. Clinical Genitourinary Cancer. 19(6). 480–490. 14 indexed citations
7.
Butler, Javed, et al.. (2021). Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry. Journal of Cardiac Failure. 27(12). 1374–1381. 15 indexed citations
8.
Januzzi, James L., Xi Tan, Lingfeng Yang, et al.. (2021). N-Terminal Pro-B-Type Natriuretic Peptide Testing Patterns in Patients with Heart Failure with Reduced Ejection Fraction. ESC Heart Failure. 9(1). 87–99. 5 indexed citations
9.
Butler, Javed, et al.. (2020). REAL WORLD STUDY OF CHARACTERISTICS AND OUTCOMES OF COMMERCIALLY INSURED PATIENTS WITH STABLE VERSUS WORSENING CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION. Journal of the American College of Cardiology. 75(11). 1014–1014. 1 indexed citations
10.
Butler, Javed, et al.. (2020). Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event. Advances in Therapy. 37(9). 4015–4032. 50 indexed citations
11.
Zhou, Wen, et al.. (2019). Long-term training in diabetes-related knowledge, attitudes, and self-reported practice among diabetes liaison nurses. Journal of International Medical Research. 48(2). 1219682390–1219682390. 7 indexed citations
12.
Lautsch, Dominik, Tongtong Wang, Lingfeng Yang, & Swapnil Rajpathak. (2019). Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK. Diabetes Therapy. 10(6). 2131–2137. 20 indexed citations
13.
Bray, Robert A., Howard M. Gebel, Robert Townsend, et al.. (2018). De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies. American Journal of Transplantation. 18(7). 1783–1789. 98 indexed citations
14.
Amin, Asim, Elizabeth R. Plimack, Marc S. Ernstoff, et al.. (2018). Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Journal for ImmunoTherapy of Cancer. 6(1). 109–109. 148 indexed citations
15.
Vincenti, Flavio, Gilles Blancho, Antoine Dürrbach, et al.. (2017). Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly. American Journal of Transplantation. 17(12). 3219–3227. 28 indexed citations
16.
Ivanoiu, Adrian, Jérémie Pariente, Kevin Booth, et al.. (2016). Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies. Alzheimer s Research & Therapy. 8(1). 24–24. 33 indexed citations
17.
Yang, Lingfeng. (2013). Influence of enteral nutrition on cardiac function and inflammatory factors in elderly patients with chronic pulmonary heart failure. 1 indexed citations
18.
Dunlop, Boadie W., Sujana Reddy, Lingfeng Yang, et al.. (2011). Symptomatic and Functional Improvement in Employed Depressed Patients. Journal of Clinical Psychopharmacology. 31(5). 569–576. 67 indexed citations
19.
Eberly, Lynn E., Judith K. Ockene, Roger Sherwin, Lingfeng Yang, & Lewis H. Kuller. (2003). Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters. International Journal of Epidemiology. 32(4). 592–599. 26 indexed citations
20.
Eberly, Lynn E., Jerome D. Cohen, Ronald J. Prineas, & Lingfeng Yang. (2003). Impact of Incident Diabetes and Incident Nonfatal Cardiovascular Disease on 18-Year Mortality. Diabetes Care. 26(3). 848–854. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026